"Lebensrettung, glückliche Geburt und kompetente Behandlung von ganz klein bis ganz groß: Das St. Vincenz Limburg ist Krankenhaus der Schwerpunktversorgung und Akademisches Lehrkrankenhaus der Justus-Liebig-Universität Gießen. Hier ist ein Onkologischer Schwerpunkt mit zertifiziertem Brustzentrum und Stroke Unit angesiedelt; ein Institut für Pathologie ist angegliedert. Darüber hinaus betreibt die Trägergesellschaft eine Akademie für Gesundheitsfachberufe, die sog. BILDUNGSWERKstadt. Mit ihren 1800 Mitarbeiter:innen, 150 Ausbildungsplätzen und rund 70 hochspezialisierten Berufsbildern nimmt die Klinik eine bedeutende Position als Wirtschaftsfaktor der Region ein."

During the past decade, St. Vincenz Krankenhaus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincenz Krankenhaus" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials sponsored, "German CLL Study Group" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "Karolinska University Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincenz Krankenhaus" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincenz Krankenhaus" are "Lymphoma" (4 trials), "Breast Cancer" (2 trials), "Hypercholesterolemia" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "St. Vincenz Krankenhaus" in a lesser frequency.

Most popular intervention types in "St. Vincenz Krankenhaus" are "Drug" (11 trials), "Biological" (7 trials), "Other" (3 trials), "Radiation" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "vincristine sulfate" (4 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincenz Krankenhaus" are 9 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "St. Vincenz Krankenhaus". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in St. Vincenz Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincenz Krankenhaus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".